File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-77954119208
- PMID: 20036934
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Molecular and functional genetics of hepatocellular carcinoma.
Title | Molecular and functional genetics of hepatocellular carcinoma. |
---|---|
Authors | |
Keywords | Epigenetics Genetic Alterations Hepatocellular Carcinoma Molecular Pathogenesis Signaling Pathways |
Issue Date | 2010 |
Citation | Frontiers In Bioscience (Scholar Edition), 2010, v. 2, p. 117-134 How to Cite? |
Abstract | Hepatocellular carcinoma (HCC) is the fifth most common cancer and one of the leading causes of cancer death worldwide. Hepatocarcinogenesis is a multistep process developing from normal through chronic hepatitis/cirrhosis and dysplastic nodules to HCC. Although we have insufficient understanding to propose a robust general model, with advances in molecular methods, there is a growing understanding of the molecular mechanisms in the development of HCC. Hepatocarcinogenesis is strongly linked to increases in allelic losses, chromosomal changes, gene mutations, epigenetic alterations, and alterations in molecular cellular pathways. Special emphasis in this review is given to the genetics, epigenetics, and regulation of major signaling pathways involved in HCC such as Wnt/b-catenin, Ras, and PI3K/Akt/mTOR pathways. A detailed understanding of the underlying molecular mechanisms involved in the progression of HCC can improve our prevention and diagnostic tools for HCC and be an important potential source of novel molecular targets for new therapies. |
Persistent Identifier | http://hdl.handle.net/10722/148624 |
ISSN | 2023 SCImago Journal Rankings: 0.559 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yam, JW | en_US |
dc.contributor.author | Wong, CM | en_US |
dc.contributor.author | Ng, IO | en_US |
dc.date.accessioned | 2012-05-29T06:14:10Z | - |
dc.date.available | 2012-05-29T06:14:10Z | - |
dc.date.issued | 2010 | en_US |
dc.identifier.citation | Frontiers In Bioscience (Scholar Edition), 2010, v. 2, p. 117-134 | en_US |
dc.identifier.issn | 1945-0524 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/148624 | - |
dc.description.abstract | Hepatocellular carcinoma (HCC) is the fifth most common cancer and one of the leading causes of cancer death worldwide. Hepatocarcinogenesis is a multistep process developing from normal through chronic hepatitis/cirrhosis and dysplastic nodules to HCC. Although we have insufficient understanding to propose a robust general model, with advances in molecular methods, there is a growing understanding of the molecular mechanisms in the development of HCC. Hepatocarcinogenesis is strongly linked to increases in allelic losses, chromosomal changes, gene mutations, epigenetic alterations, and alterations in molecular cellular pathways. Special emphasis in this review is given to the genetics, epigenetics, and regulation of major signaling pathways involved in HCC such as Wnt/b-catenin, Ras, and PI3K/Akt/mTOR pathways. A detailed understanding of the underlying molecular mechanisms involved in the progression of HCC can improve our prevention and diagnostic tools for HCC and be an important potential source of novel molecular targets for new therapies. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Frontiers in bioscience (Scholar edition) | en_US |
dc.subject | Epigenetics | - |
dc.subject | Genetic Alterations | - |
dc.subject | Hepatocellular Carcinoma | - |
dc.subject | Molecular Pathogenesis | - |
dc.subject | Signaling Pathways | - |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Carcinoma, Hepatocellular - Genetics - Physiopathology | en_US |
dc.subject.mesh | Chromosome Aberrations | en_US |
dc.subject.mesh | Epigenesis, Genetic | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Intracellular Signaling Peptides And Proteins - Metabolism | en_US |
dc.subject.mesh | Liver Neoplasms - Genetics - Physiopathology | en_US |
dc.subject.mesh | Mice | en_US |
dc.subject.mesh | Mice, Knockout | en_US |
dc.subject.mesh | Mutation - Genetics | en_US |
dc.subject.mesh | P-Glycoproteins - Genetics | en_US |
dc.subject.mesh | Phosphatidylinositol 3-Kinases - Metabolism | en_US |
dc.subject.mesh | Polymorphism, Single Nucleotide | en_US |
dc.subject.mesh | Protein-Serine-Threonine Kinases - Metabolism | en_US |
dc.subject.mesh | Proto-Oncogene Proteins C-Akt - Metabolism | en_US |
dc.subject.mesh | Signal Transduction - Genetics - Physiology | en_US |
dc.subject.mesh | Tor Serine-Threonine Kinases | en_US |
dc.subject.mesh | Wnt Proteins - Metabolism | en_US |
dc.subject.mesh | Beta Catenin - Metabolism | en_US |
dc.subject.mesh | Ras Proteins - Metabolism | en_US |
dc.title | Molecular and functional genetics of hepatocellular carcinoma. | en_US |
dc.type | Article | en_US |
dc.identifier.email | Yam, JW:judyyam@pathology.hku.hk | en_US |
dc.identifier.email | Wong, CM:jackwong@pathology.hku.hk | en_US |
dc.identifier.email | Ng, IO:iolng@hkucc.hku.hk | en_US |
dc.identifier.authority | Yam, JW=rp00468 | en_US |
dc.identifier.authority | Wong, CM=rp00231 | en_US |
dc.identifier.authority | Ng, IO=rp00335 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 20036934 | - |
dc.identifier.scopus | eid_2-s2.0-77954119208 | en_US |
dc.identifier.hkuros | 171419 | - |
dc.identifier.volume | 2 | en_US |
dc.identifier.spage | 117 | en_US |
dc.identifier.epage | 134 | en_US |
dc.identifier.issnl | 1945-0516 | - |